Many of the identified differentially expressed genes are understudied in glioblastoma; however, several are key regulators of tissue remodeling (MFAP4 and ALX4), mesoderm development (TBX5 and ALX4), and immune modulation (FUT2, C4BPA, MFAP4, and GRM4). The gene discussed is C4BPA; the disease is glioblastoma.